RELMADA THERAPEUTICS INC (RLMD)
US75955J4022 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -86.49M | -98.79M | -157.04M | -125.75M | -59.46M | |||
| Depreciation Amortization | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Change In Working Capital | 943.59K | 3.08M | 10.59M | -7.86M | 10.85M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 32.34M | 44.05M | 42.65M | 41.74M | 20.79M | |||
| OPERATING CASH FLOW | -53.21M | -51.66M | -103.80M | -91.87M | -27.81M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| Other Investing Activity | 47.96M | 50.45M | 19.73M | -54.12M | -34.45M | |||
| INVESTING CASH FLOW | 47.96M | 50.45M | 19.73M | -54.12M | -34.45M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | -110.00K | |||
| Stock Issued/Repurchased | 246.75K | 0.00 | 44.65M | 187.94M | 28.58M | |||
| Other Financing Activity | N/A | -98.46K | 370.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 33.69K | -98.46K | 45.02M | 187.94M | 28.47M | |||
| CHANGE IN CASH | -5.21M | -1.30M | -39.05M | 41.95M | -33.79M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -53.21M | -51.66M | -103.80M | -91.87M | -27.81M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | -53.21M | -51.66M | -103.80M | -91.87M | -27.81M | |||
All data in USD